Effectiveness of Cognitive Stimulation Treatment in Patients With Parkinson's Disease

Recruiting Observational Study
Parkinson Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Observational
Participants needed
68 (estimated)
Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this observational study is to evaluate the relationship between GBA mutation and cognitive stimulation treatment response in patients with Parkinson's disease. The main questions it aim to answer are: • assess whether the GBA mutation is associated with greater or lesser response to cognitive training treatment compared to a control group of PD patients without genetic mutations. • in…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients with Parkinson's disease according to the Gelb et al. criteria; * Patients who have carried out genetic screening for MP; * Patients who have a raw score in the range 15.50 to 22.23 at Montreal cognitive assessment (MoCA); * Patients who have signed the informed conse…
Contacts

Fabiana Ruggiero, MSc in Psychology

+390255033621

fabiana.ruggiero@policlinico.mi.it

CONTACT

Francesca Mameli, MSc in Psychology

+390255033621

francesca.mameli@policlinico.mi.it

CONTACT